AC
TARO

Aristides Capital’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Aristides Capital’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,579
Closed -$219K – 182
2020
Q1 		$219K Buy
+3,579
New +$265K 0.16% 103

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Aristides Capital's TARO Position: Q2 2020 in Review

Aristides Capital sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2020, closing a stake of 3,579 shares — an estimated $219K sold.

Aristides Capital first reported a position in TARO in Q1 2020 and held it in 1 quarter. The position peaked at $219K in Q1 2020. 84 funds tracked by Wall St. Rank hold TARO as of Q2 2020.

  • Aristides Capital reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2020 after selling out during the quarter.
  • Aristides Capital sold 3,579 Taro Pharmaceutical Industries Ltd. shares in Q2 2020, an estimated $219K.
  • Aristides Capital first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2020 and held it in 1 quarter.
  • Aristides Capital's Taro Pharmaceutical Industries Ltd. position peaked at $219K in Q1 2020.
  • 84 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2020.

Based on Aristides Capital's 13F filing for Q2 2020, filed 14 Aug 2020.